Pipecuronium
MUSCULO-SKELETAL SYSTEM
Also known as: pipecuronium bromide
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Pipecuronium is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1990. DrugCentral lists 4 molecular targets, including CHRNB4|CHRNA2, CHRNA1|CHRNB1|CHRND and CHRNB2|CHRNA4. Recorded indications include Muscle relaxation, function.
- Approval status: ofm (first approved 1990 by the FDA).
- Molecular targets: CHRNB4|CHRNA2, CHRNA1|CHRNB1|CHRND, CHRNB2|CHRNA4 and CHRNB4|CHRNA4 (4 listed in DrugCentral).
- Indications: Muscle relaxation, function.
- ATC code: M03AC06 (Other quaternary ammonium compounds).
- Molecular formula: C35H62N4O4; molecular weight 602.90 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Muscle relaxation, function
Mechanism & targets
Molecular targets (4)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Neuronal acetylcholine receptor; alpha2/beta4 | CHRNB4|CHRNA2 | unknown | — |
| Acetylcholine receptor | CHRNA1|CHRNB1|CHRND | antagonist | — |
| Neuronal acetylcholine receptor; alpha4/beta2 | CHRNB2|CHRNA4 | unknown | — |
| Neuronal acetylcholine receptor; alpha4/beta4 | CHRNB4|CHRNA4 | unknown | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1990-06-26 | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
M03AC06 | MUSCULO-SKELETAL SYSTEM › MUSCLE RELAXANTS › MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS › Other quaternary ammonium compounds |
Chemical structure
| Molecular formula | C35H62N4O4 |
|---|---|
| Molecular weight | 602.90 g/mol |
| CAS number | 68399-58-6 |
| InChIKey | OWWLUIWOFHMHOQ-XGHATYIMSA-N |
| PubChem CID | 50192 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Pipecuronium used for?
DrugCentral lists the following indications for Pipecuronium: Muscle relaxation, function.
How does Pipecuronium work?
Its molecular targets in DrugCentral include CHRNB4|CHRNA2, CHRNA1|CHRNB1|CHRND (antagonist), CHRNB2|CHRNA4 and CHRNB4|CHRNA4.
When was Pipecuronium first approved?
Pipecuronium was first approved by the FDA in 1990.
What is the chemical formula of Pipecuronium?
Pipecuronium has the molecular formula C35H62N4O4 and a molecular weight of 602.90 g/mol.
Browse: all drugs starting with P · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2183 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200722 — compound record and bioactivity
- PubChem CID 50192 — chemical identifiers
- DrugBank DB01338 — drug record
- FDA UNII 1N3O74HM92 — substance identity
- DailyMed: FDA labels for Pipecuronium — current prescribing information (label search)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.